C-peptide modifies leptin and visfatin secretion in human adipose tissue

Obesity

Volumn 23, Issue 8, 2015, Pages 1607-1615

  Garcia Serrano, Sara ^a,b   Gutiérrez Repiso, Carolina ^a   Gonzalo, Montserrat ^a   Garcia Arnes, Juan ^a   Valdes, Sergio ^a,b   Soriguer, Federico ^a,b,c   Perez Valero, Vidal ^a   Alaminos Castillo, Miguel A ^a   Francisco Cobos Bravo, Juan ^a   Moreno Ruiz, Francisco J ^a   Rodriguez Cañete, Alberto ^a   Rodríguez Pacheco, Francisca ^a,b   Garcia Escobar, Eva ^a,b   García Fuentes, Eduardo ^a,c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C PEPTIDE; CCAAT ENHANCER BINDING PROTEIN ALPHA; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B INHIBITOR; RHODAMINE; PHOSPHATIDYLINOSITOL 3 KINASE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AREA UNDER THE CURVE; ARTICLE; C EBP ALPHA GENE; CELL VIABILITY; CHEMICAL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPLANT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; INTRAVENOUS GLUCOSE TOLERANCE TEST; IRS 1 GENE; MALE; MORBID OBESITY; PHARMACOLOGICAL BLOCKING; PROTEIN SECRETION; BLOOD; CHEMISTRY; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; PROCEDURES;

ADIPOKINES; ADIPOSE TISSUE; ADULT; C-PEPTIDE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LEPTIN; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84937513275     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21137     Document Type: Article

References (35)

1. Torn C,. Cpeptide and autoimmune markers in diabetes. Clin Lab 2003; 49: 1-10.
2. Polonsky KS, Licinio-Paixao J, Given BD, et al., Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 1986; 77: 98-105.
3. Ghorbani A, Omrani GR, Hadjzadeh MA, Varedi M,. Effects of rat C-peptide-II on lipolysis and glucose consumption in cultured rat adipose tissue. Exp Clin Endocrinol Diabetes 2011; 119: 343-347.
4. Ghorbani A, Omrani GR, Hadjzadeh MA, Varedi M,. Proinsulin C-peptide inhibits lipolysis in diabetic rat adipose tissue through phosphodiestrase-3B enzyme. Horm Metab Res 2013; 45: 221-225.
5. Hills CE, Brunskill NJ,. Cellular and physiological effects of C-peptide. Clin Sci (Lond) 2009; 116: 565-574.
6. Grunberger G, Sima AA,. The C-peptide signaling. Exp Diabesity Res 2004; 5: 25-36.
7. Zierath JR, Galuska D, Johansson BL, Wallberg-Henriksson H,. Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia 1991; 34: 899-901.
8. Meier U, Gressner AM,. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
9. Gutiérrez-Repiso C, Velasco I, Garcia-Escobar E, et al., Does dietary iodine regulate oxidative stress and adiponectin levels in human breast milk? Antioxid Redox Signal 2014; 20: 847-853.
10. Soliman MM, Ahmed MM, Salah-Eldin AE, Abdel-Aal AA,. Butyrate regulates leptin expression through different signaling pathways in adipocytes. J Vet Sci 2011; 12: 319-323.
11. Rabe K, Lehrke M, Parhofer KG, Broedl UC,. Adipokines and insulin resistance. Mol Med 2008; 14: 741-51.
12. Fukuhara A, Matsuda M, Nishizawa M, et al., Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
13. García-Fuentes E, García-Almeida JM, García-Arnés J, et al., Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007; 15: 2391-2395.
14. Romacho T, Sanchez-Ferrer CF, Peiro C,. Visfatin/nampt: an adipokine with cardiovascular impact. Mediators Inflamm 2013;2013: 946427.
15. Kralisch S, Klein J, Lossner U, et al., Hormonal regulation of the novel adipocytokine visfatin in 3T3-l1 adipocytes. J Endocrinol 2005; 185: R1-R8.
16. García-Fuentes E, García-Almeida JM, García-Arnés J, et al., Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes. Surg 2006; 16: 1179-1188.
17. Soriguer F, García-Serrano S, García-Almeida JM, et al., Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring) 2009; 17: 10-15.
18. Mittelman SD, Van Citters GW, Kim SP, et al., Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 2000; 49: 2116-2125.
19. Teff KL, Townsend RR,. Prolonged mild hyperglycemia induces vagally mediated compensatory increase in C-peptide secretion in humans. J Clin Endocrinol Metab 2004; 89: 5606-5613.
20. García-Serrano S, Moreno-Santos I, Garrido-Sánchez L, et al., Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects. Mol Med 2011; 17: 273-280.
21. Garrido-Sanchez L, Escote X, Coin-Aragüez L, et al., Munc18c in adipose tissue is downregulated in obesity and is associated with insulin. PLoS One 2013; 8: e63937.
22. Rodriguez-Pacheco F, Garcia-Serrano S, Garcia-Escobar E, et al., Effects of obesity/fatty acids on the expression of GPR120. Mol Nutr Food Res 2014; 58: 1852-1860.
23. Lindahl E, Nyman U, Melles E, et al., Cellular internalization of proinsulin C-peptide. Cell Mol Life Sci 2007; 64: 479-486.
24. Abdullah A, Hasan H, Raigangar V, Bani-Issa W,. Cpeptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young arab females. Int J Endocrinol 2012; 2012: 420792.
25. Pham MN, Kolb H, Mandrup-Poulsen T, et al., Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes. Metab Res Rev 2013; 29: 166-170.
26. Al-Suhaimi EA, Shehzad A,. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res 2013; 18: 12.
27. Rigler R, Pramanik A, Jonasson P, et al., Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999; 96: 13318-13323.
28. Henriksson M, Pramanik A, Shafqat J, et al., Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts. Biochem Biophys Res Commun 2001; 280: 423-427.
29. Pramanik A, Ekberg K, Zhong Z, et al., C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 2001; 284: 94-98.
30. Clark JL, Cho S, Rubenstein AH, Steiner DF,. Isolation of a proinsulin connecting peptide fragment (C-peptide) from bovine and human pancreas. Biochem Biophys Res Commun 1969; 35: 456-461.
31. Fried SK, Moustaid-Moussa N,. Culture of adipose tissue and isolated adipocytes. Methods Mol Biol 2001; 155: 197-212.
32. Tinahones FJ, Garrido-Sanchez L, Miranda M, et al., Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 2010; 20: 1559-1567.
33. Rasouli N, Yao BA, Miles LM, Elbein SC, Kern PA,. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 2006; 290: 42-46.
34. Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW,. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2012; 21: 643-651.
35. Coelho M, Oliveira T, Fernandes R,. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 2013; 9: 191-200.